Indeed, we found that blocking TGFβ1 with anti-TGFβ1 antibody could reduce the phosphorylation of ERK and AKT in pancreatic cancer, while treating with TGFβ1 protein showed the opposed effect. This evidence concerns the gene AKT1 and pancreatic neoplasm.